Skip to main content
Biomolecules & Therapeutics logoLink to Biomolecules & Therapeutics
. 2021 Jul 1;29(4):454. doi: 10.4062/biomolther.2021.454

Erratum to "Melatonin-Induced PGC-1α Improves Angiogenic Potential of Mesenchymal Stem Cells in Hindlimb Ischemia" [Biomol. Ther. 28 (2020) 240-249]

Jun Hee Lee 1,2, Yong-Seok Han 1, Sang Hun Lee 1,2,*
PMCID: PMC8255134  PMID: 34183472

After publication of the paper “Melatonin-Induced PGC-1α Improves Angiogenic Potential of Mesenchymal Stem Cells in Hindlimb Ischemia” by Lee et al. (2020), it was noticed that paper contains an error in Fig. 3C. Because of an unintentional error made during the preparation of the results, the authors mistakenly used the unmatched image of Transwell invasion assay. The authors wish to replace the image of Transwell invasion assay in Fig. 3C.

Fig. 3.

Fig. 3

(C) Transwell invasion assay in MSCs treated with melatonin. Scale bar=100 μm.

The corrected Fig. 3C is published here to avoid confusion for readers. The conclusion of the article is unaffected by the error. The authors apologize for this inadvertent error and for any inconvenience caused.

Footnotes

REFERENCE

  1. Lee J. H., Han Y. S., Lee S. H. Melatonin-induced PGC-1alpha improves angiogenic potential of mesenchymal stem cells in hindlimb ischemia. Biomol. Ther. (Seoul) 2020;28:240–249. doi: 10.4062/biomolther.2019.131. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Biomolecules & Therapeutics are provided here courtesy of Korean Society of Applied Pharmacology

RESOURCES